New York, NY, United States of America

Excaliard Pharmaceuticals, Inc.


USPTO Granted Patents = 6



Forward Citations = 5

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Nicholas M Dean (6 out of 54 patents)

silverMedal C Frank Bennett (5 out of 202 patents)

bronzeMedal Niall O'Donnell (5 out of 9 patents)

4 J Gordon Foulkes (5 out of 6 patents)

5 Susan M Frier (3 out of 3 patents)

6 Susan M Freier (1 out of 254 patents)

7 Thomas A Mustoe (1 out of 6 patents)

8 Lincoln Krochmal (1 out of 1 patent)

9 Leroy Young (1 out of 2 patents)

10 Mark Jewell (1 out of 1 patent)

11 Mark Sisco (1 out of 1 patent)

12 Zol Kryger (1 out of 1 patent)

13 Gregory E Hardee (1 out of 9 patents)

14 Niall O'donnell (1 patent)

15 Frank C Bennet (0 patent)


6 patents:

Excaliard Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel treatments for fibrotic diseases. Their lead product candidate is a proprietary anti-sense oligonucleotide designed to prevent the formation of excessive scar tissue. The company's mission is to improve the lives of patients suffering from debilitating fibrotic conditions through innovative therapies.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#946 in New York, NY

#2,569 in New York

#43,798 in US

...
New York, NY, United States of America
Forward Citations = 5

13 inventors:

Please report any incorrect information to support@idiyas.com
Loading…